nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—CYP3A4—Temozolomide—malignant glioma	0.182	1	CbGbCtD
Methylergometrine—HTR2C—choroid plexus—malignant glioma	0.123	0.191	CbGeAlD
Methylergometrine—HTR2A—choroid plexus—malignant glioma	0.0617	0.096	CbGeAlD
Methylergometrine—DRD1—telencephalic ventricle—malignant glioma	0.0464	0.0722	CbGeAlD
Methylergometrine—HTR2C—telencephalic ventricle—malignant glioma	0.0361	0.0561	CbGeAlD
Methylergometrine—HTR2A—cerebellar cortex—malignant glioma	0.0311	0.0484	CbGeAlD
Methylergometrine—HTR1F—telencephalon—malignant glioma	0.022	0.0343	CbGeAlD
Methylergometrine—HTR2A—pons—malignant glioma	0.022	0.0342	CbGeAlD
Methylergometrine—HTR2A—vertebral column—malignant glioma	0.0218	0.0339	CbGeAlD
Methylergometrine—HTR1E—brainstem—malignant glioma	0.0215	0.0335	CbGeAlD
Methylergometrine—HTR1E—telencephalon—malignant glioma	0.0191	0.0297	CbGeAlD
Methylergometrine—HTR2A—telencephalic ventricle—malignant glioma	0.0181	0.0281	CbGeAlD
Methylergometrine—HTR2A—pineal body—malignant glioma	0.0157	0.0244	CbGeAlD
Methylergometrine—DRD1—brainstem—malignant glioma	0.0126	0.0195	CbGeAlD
Methylergometrine—HTR1F—central nervous system—malignant glioma	0.0125	0.0195	CbGeAlD
Methylergometrine—DRD1—telencephalon—malignant glioma	0.0111	0.0173	CbGeAlD
Methylergometrine—HTR1E—central nervous system—malignant glioma	0.0109	0.0169	CbGeAlD
Methylergometrine—HTR1F—brain—malignant glioma	0.00995	0.0155	CbGeAlD
Methylergometrine—HTR2C—brainstem—malignant glioma	0.00976	0.0152	CbGeAlD
Methylergometrine—HTR2A—endothelium—malignant glioma	0.00971	0.0151	CbGeAlD
Methylergometrine—HTR2A—blood vessel—malignant glioma	0.00895	0.0139	CbGeAlD
Methylergometrine—HTR2C—telencephalon—malignant glioma	0.00866	0.0135	CbGeAlD
Methylergometrine—HTR1E—brain—malignant glioma	0.00862	0.0134	CbGeAlD
Methylergometrine—HTR2B—telencephalon—malignant glioma	0.00813	0.0126	CbGeAlD
Methylergometrine—DRD1—midbrain—malignant glioma	0.008	0.0124	CbGeAlD
Methylergometrine—Vasospasm—Carmustine—malignant glioma	0.00776	0.17	CcSEcCtD
Methylergometrine—HTR2C—medulla oblongata—malignant glioma	0.0068	0.0106	CbGeAlD
Methylergometrine—DRD1—central nervous system—malignant glioma	0.00634	0.00985	CbGeAlD
Methylergometrine—HTR2C—midbrain—malignant glioma	0.00622	0.00967	CbGeAlD
Methylergometrine—HTR2C—spinal cord—malignant glioma	0.00607	0.00943	CbGeAlD
Methylergometrine—HTR2A—embryo—malignant glioma	0.00534	0.0083	CbGeAlD
Methylergometrine—DRD1—brain—malignant glioma	0.00503	0.00782	CbGeAlD
Methylergometrine—HTR2C—central nervous system—malignant glioma	0.00492	0.00765	CbGeAlD
Methylergometrine—HTR2A—brainstem—malignant glioma	0.00489	0.00761	CbGeAlD
Methylergometrine—HTR2A—retina—malignant glioma	0.00472	0.00734	CbGeAlD
Methylergometrine—HTR2B—central nervous system—malignant glioma	0.00462	0.00719	CbGeAlD
Methylergometrine—HTR2A—telencephalon—malignant glioma	0.00434	0.00675	CbGeAlD
Methylergometrine—HTR2C—brain—malignant glioma	0.00391	0.00608	CbGeAlD
Methylergometrine—HTR2B—brain—malignant glioma	0.00367	0.00571	CbGeAlD
Methylergometrine—HTR2A—medulla oblongata—malignant glioma	0.00341	0.00531	CbGeAlD
Methylergometrine—HTR2A—midbrain—malignant glioma	0.00312	0.00485	CbGeAlD
Methylergometrine—HTR2A—spinal cord—malignant glioma	0.00304	0.00473	CbGeAlD
Methylergometrine—HTR2A—central nervous system—malignant glioma	0.00247	0.00384	CbGeAlD
Methylergometrine—HTR2A—cerebellum—malignant glioma	0.00241	0.00375	CbGeAlD
Methylergometrine—CYP3A4—central nervous system—malignant glioma	0.00229	0.00355	CbGeAlD
Methylergometrine—Thrombophlebitis—Carmustine—malignant glioma	0.00222	0.0486	CcSEcCtD
Methylergometrine—Thrombophlebitis—Temozolomide—malignant glioma	0.00215	0.0469	CcSEcCtD
Methylergometrine—Nasal congestion—Temozolomide—malignant glioma	0.00204	0.0446	CcSEcCtD
Methylergometrine—HTR2A—brain—malignant glioma	0.00196	0.00305	CbGeAlD
Methylergometrine—Sweating increased—Temozolomide—malignant glioma	0.00157	0.0342	CcSEcCtD
Methylergometrine—Hallucination—Carmustine—malignant glioma	0.00133	0.0289	CcSEcCtD
Methylergometrine—Hallucination—Temozolomide—malignant glioma	0.00128	0.028	CcSEcCtD
Methylergometrine—Tinnitus—Temozolomide—malignant glioma	0.0012	0.0262	CcSEcCtD
Methylergometrine—Cardiac disorder—Temozolomide—malignant glioma	0.00119	0.0261	CcSEcCtD
Methylergometrine—Convulsion—Carmustine—malignant glioma	0.001	0.0219	CcSEcCtD
Methylergometrine—Hypertension—Carmustine—malignant glioma	0.001	0.0219	CcSEcCtD
Methylergometrine—Palpitations—Temozolomide—malignant glioma	0.00099	0.0216	CcSEcCtD
Methylergometrine—Chest pain—Carmustine—malignant glioma	0.000987	0.0216	CcSEcCtD
Methylergometrine—Convulsion—Temozolomide—malignant glioma	0.000971	0.0212	CcSEcCtD
Methylergometrine—Hypertension—Temozolomide—malignant glioma	0.000967	0.0211	CcSEcCtD
Methylergometrine—Tachycardia—Carmustine—malignant glioma	0.000923	0.0202	CcSEcCtD
Methylergometrine—Anaphylactic shock—Temozolomide—malignant glioma	0.000914	0.02	CcSEcCtD
Methylergometrine—Nervous system disorder—Temozolomide—malignant glioma	0.000897	0.0196	CcSEcCtD
Methylergometrine—Hypotension—Carmustine—malignant glioma	0.000884	0.0193	CcSEcCtD
Methylergometrine—Hyperhidrosis—Temozolomide—malignant glioma	0.000884	0.0193	CcSEcCtD
Methylergometrine—Paraesthesia—Carmustine—malignant glioma	0.00085	0.0186	CcSEcCtD
Methylergometrine—Dyspnoea—Carmustine—malignant glioma	0.000844	0.0184	CcSEcCtD
Methylergometrine—Paraesthesia—Temozolomide—malignant glioma	0.000821	0.0179	CcSEcCtD
Methylergometrine—Dyspnoea—Temozolomide—malignant glioma	0.000815	0.0178	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Carmustine—malignant glioma	0.000774	0.0169	CcSEcCtD
Methylergometrine—Abdominal pain—Carmustine—malignant glioma	0.000748	0.0163	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000748	0.0163	CcSEcCtD
Methylergometrine—Abdominal pain—Temozolomide—malignant glioma	0.000723	0.0158	CcSEcCtD
Methylergometrine—Diarrhoea—Carmustine—malignant glioma	0.000647	0.0141	CcSEcCtD
Methylergometrine—Dizziness—Carmustine—malignant glioma	0.000626	0.0137	CcSEcCtD
Methylergometrine—Diarrhoea—Temozolomide—malignant glioma	0.000626	0.0137	CcSEcCtD
Methylergometrine—Dizziness—Temozolomide—malignant glioma	0.000605	0.0132	CcSEcCtD
Methylergometrine—Vomiting—Carmustine—malignant glioma	0.000602	0.0131	CcSEcCtD
Methylergometrine—Rash—Carmustine—malignant glioma	0.000597	0.013	CcSEcCtD
Methylergometrine—Dermatitis—Carmustine—malignant glioma	0.000596	0.013	CcSEcCtD
Methylergometrine—Headache—Carmustine—malignant glioma	0.000593	0.0129	CcSEcCtD
Methylergometrine—Vomiting—Temozolomide—malignant glioma	0.000581	0.0127	CcSEcCtD
Methylergometrine—Rash—Temozolomide—malignant glioma	0.000577	0.0126	CcSEcCtD
Methylergometrine—Dermatitis—Temozolomide—malignant glioma	0.000576	0.0126	CcSEcCtD
Methylergometrine—Headache—Temozolomide—malignant glioma	0.000573	0.0125	CcSEcCtD
Methylergometrine—Nausea—Carmustine—malignant glioma	0.000562	0.0123	CcSEcCtD
Methylergometrine—Nausea—Temozolomide—malignant glioma	0.000543	0.0119	CcSEcCtD
Methylergometrine—DRD1—Signaling by GPCR—CXCL8—malignant glioma	4.98e-05	0.000387	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PTPN11—malignant glioma	4.93e-05	0.000383	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PDGFB—malignant glioma	4.9e-05	0.000381	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOTCH2—malignant glioma	4.9e-05	0.000381	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP3—malignant glioma	4.89e-05	0.00038	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGFR1—malignant glioma	4.88e-05	0.000379	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PIK3CB—malignant glioma	4.88e-05	0.000379	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PIK3CD—malignant glioma	4.86e-05	0.000378	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDKN2B—malignant glioma	4.85e-05	0.000377	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AKT1—malignant glioma	4.83e-05	0.000375	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HIF1A—malignant glioma	4.8e-05	0.000373	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KNG1—malignant glioma	4.79e-05	0.000373	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MMP9—malignant glioma	4.79e-05	0.000373	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CASP3—malignant glioma	4.78e-05	0.000372	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL2—malignant glioma	4.78e-05	0.000371	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PTEN—malignant glioma	4.76e-05	0.00037	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL2—malignant glioma	4.75e-05	0.00037	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TERT—malignant glioma	4.74e-05	0.000368	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTK2—malignant glioma	4.71e-05	0.000366	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL8—malignant glioma	4.69e-05	0.000364	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AKT1—malignant glioma	4.65e-05	0.000361	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CAV1—malignant glioma	4.65e-05	0.000361	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HES1—malignant glioma	4.63e-05	0.00036	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PDGFB—malignant glioma	4.62e-05	0.000359	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGFR1—malignant glioma	4.6e-05	0.000358	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NCOR1—malignant glioma	4.6e-05	0.000357	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KDR—malignant glioma	4.59e-05	0.000357	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKT2—malignant glioma	4.59e-05	0.000357	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NTRK1—malignant glioma	4.57e-05	0.000355	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—RAF1—malignant glioma	4.54e-05	0.000353	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HIF1A—malignant glioma	4.53e-05	0.000352	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MMP9—malignant glioma	4.52e-05	0.000351	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PTEN—malignant glioma	4.49e-05	0.000349	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—IL2—malignant glioma	4.48e-05	0.000348	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PIK3CB—malignant glioma	4.43e-05	0.000344	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FN1—malignant glioma	4.42e-05	0.000344	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—F2—malignant glioma	4.42e-05	0.000344	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PIK3CD—malignant glioma	4.41e-05	0.000343	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—IDH2—malignant glioma	4.41e-05	0.000343	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PDGFRA—malignant glioma	4.4e-05	0.000342	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AKT1—malignant glioma	4.38e-05	0.000341	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CAV1—malignant glioma	4.38e-05	0.000341	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—BAD—malignant glioma	4.37e-05	0.00034	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KDR—malignant glioma	4.33e-05	0.000337	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOTCH1—malignant glioma	4.33e-05	0.000336	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—malignant glioma	4.3e-05	0.000334	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SPP1—malignant glioma	4.28e-05	0.000332	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—STAT3—malignant glioma	4.26e-05	0.000331	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL8—malignant glioma	4.26e-05	0.000331	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP3—malignant glioma	4.25e-05	0.00033	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CD80—malignant glioma	4.24e-05	0.00033	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PIK3CB—malignant glioma	4.24e-05	0.000329	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—APC—malignant glioma	4.23e-05	0.000329	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CG—malignant glioma	4.23e-05	0.000329	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDKN2B—malignant glioma	4.21e-05	0.000327	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGF—malignant glioma	4.18e-05	0.000325	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—F2—malignant glioma	4.17e-05	0.000324	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FN1—malignant glioma	4.17e-05	0.000324	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTPN11—malignant glioma	4.16e-05	0.000323	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.14e-05	0.000322	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—BAD—malignant glioma	4.12e-05	0.00032	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTK2—malignant glioma	4.09e-05	0.000318	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOTCH1—malignant glioma	4.08e-05	0.000317	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL8—malignant glioma	4.07e-05	0.000316	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL2—malignant glioma	4.07e-05	0.000316	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—malignant glioma	4.06e-05	0.000316	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TERT—malignant glioma	4.05e-05	0.000315	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STAT3—malignant glioma	4.02e-05	0.000312	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HES1—malignant glioma	4.02e-05	0.000312	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CD80—malignant glioma	4e-05	0.000311	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NCOR1—malignant glioma	3.99e-05	0.00031	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APC—malignant glioma	3.99e-05	0.00031	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CG—malignant glioma	3.99e-05	0.00031	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—BRAF—malignant glioma	3.98e-05	0.000309	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MYC—malignant glioma	3.96e-05	0.000308	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PDGFB—malignant glioma	3.96e-05	0.000307	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGF—malignant glioma	3.95e-05	0.000307	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—RAF1—malignant glioma	3.94e-05	0.000306	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGFR1—malignant glioma	3.94e-05	0.000306	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTPN11—malignant glioma	3.92e-05	0.000305	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL2—malignant glioma	3.89e-05	0.000302	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HIF1A—malignant glioma	3.88e-05	0.000301	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EGFR—malignant glioma	3.87e-05	0.000301	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKT2—malignant glioma	3.87e-05	0.000301	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EGFR—malignant glioma	3.86e-05	0.0003	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PIK3CB—malignant glioma	3.85e-05	0.000299	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PDGFRA—malignant glioma	3.82e-05	0.000297	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—IDH1—malignant glioma	3.79e-05	0.000295	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—BRAF—malignant glioma	3.75e-05	0.000292	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CAV1—malignant glioma	3.75e-05	0.000291	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MYC—malignant glioma	3.73e-05	0.00029	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	3.72e-05	0.000289	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SPP1—malignant glioma	3.71e-05	0.000289	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KDR—malignant glioma	3.71e-05	0.000288	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL8—malignant glioma	3.7e-05	0.000287	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	3.69e-05	0.000286	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SPHK1—malignant glioma	3.67e-05	0.000285	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—KRAS—malignant glioma	3.66e-05	0.000284	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EGFR—malignant glioma	3.65e-05	0.000284	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT2—malignant glioma	3.65e-05	0.000284	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—KRAS—malignant glioma	3.64e-05	0.000283	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EGFR—malignant glioma	3.64e-05	0.000283	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.59e-05	0.000279	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FN1—malignant glioma	3.57e-05	0.000277	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—F2—malignant glioma	3.57e-05	0.000277	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGF2—malignant glioma	3.56e-05	0.000277	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL2—malignant glioma	3.53e-05	0.000275	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BAD—malignant glioma	3.53e-05	0.000274	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TERT—malignant glioma	3.52e-05	0.000274	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CD—malignant glioma	3.51e-05	0.000273	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOTCH1—malignant glioma	3.49e-05	0.000271	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—PIK3CA—malignant glioma	3.48e-05	0.00027	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—KRAS—malignant glioma	3.45e-05	0.000268	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—KRAS—malignant glioma	3.44e-05	0.000267	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PDGFB—malignant glioma	3.43e-05	0.000267	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CD80—malignant glioma	3.42e-05	0.000266	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGFR1—malignant glioma	3.42e-05	0.000266	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APC—malignant glioma	3.41e-05	0.000265	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CG—malignant glioma	3.41e-05	0.000265	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGF—malignant glioma	3.38e-05	0.000262	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HIF1A—malignant glioma	3.37e-05	0.000262	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PIK3CA—malignant glioma	3.36e-05	0.000261	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGF2—malignant glioma	3.36e-05	0.000261	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTPN11—malignant glioma	3.35e-05	0.000261	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	3.35e-05	0.00026	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MDM2—malignant glioma	3.33e-05	0.000259	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RAF1—malignant glioma	3.32e-05	0.000258	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ERBB2—malignant glioma	3.29e-05	0.000255	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CAV1—malignant glioma	3.26e-05	0.000253	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—malignant glioma	3.25e-05	0.000253	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	3.24e-05	0.000252	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KDR—malignant glioma	3.22e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BRAF—malignant glioma	3.21e-05	0.000249	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PIK3CA—malignant glioma	3.17e-05	0.000246	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PIK3CA—malignant glioma	3.16e-05	0.000245	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MDM2—malignant glioma	3.14e-05	0.000244	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RAF1—malignant glioma	3.13e-05	0.000243	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT2—malignant glioma	3.12e-05	0.000243	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL8—malignant glioma	3.12e-05	0.000242	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EGFR—malignant glioma	3.11e-05	0.000242	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ERBB2—malignant glioma	3.1e-05	0.000241	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—F2—malignant glioma	3.1e-05	0.000241	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FN1—malignant glioma	3.1e-05	0.000241	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—malignant glioma	3.07e-05	0.000238	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BAD—malignant glioma	3.06e-05	0.000238	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CB—malignant glioma	3.06e-05	0.000238	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	3.03e-05	0.000236	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	3.01e-05	0.000234	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	3e-05	0.000233	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CASP3—malignant glioma	2.98e-05	0.000232	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL2—malignant glioma	2.98e-05	0.000232	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	2.97e-05	0.000231	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CD80—malignant glioma	2.97e-05	0.000231	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APC—malignant glioma	2.97e-05	0.00023	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	2.97e-05	0.00023	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL8—malignant glioma	2.94e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—KRAS—malignant glioma	2.94e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGF—malignant glioma	2.93e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTPN11—malignant glioma	2.91e-05	0.000226	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTT1—malignant glioma	2.91e-05	0.000226	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGF2—malignant glioma	2.87e-05	0.000223	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AKT1—malignant glioma	2.84e-05	0.000221	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—malignant glioma	2.82e-05	0.000219	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CASP3—malignant glioma	2.81e-05	0.000219	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL2—malignant glioma	2.81e-05	0.000218	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTEN—malignant glioma	2.8e-05	0.000218	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BRAF—malignant glioma	2.79e-05	0.000217	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKT1—malignant glioma	2.75e-05	0.000213	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AKT1—malignant glioma	2.73e-05	0.000213	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS1—malignant glioma	2.72e-05	0.000212	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT2—malignant glioma	2.71e-05	0.000211	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	2.7e-05	0.00021	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	2.7e-05	0.00021	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MDM2—malignant glioma	2.69e-05	0.000209	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RAF1—malignant glioma	2.68e-05	0.000208	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—malignant glioma	2.66e-05	0.000207	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	2.65e-05	0.000206	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTEN—malignant glioma	2.64e-05	0.000205	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	2.62e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	2.61e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKT1—malignant glioma	2.59e-05	0.000201	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.58e-05	0.000201	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AKT1—malignant glioma	2.58e-05	0.0002	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	2.55e-05	0.000198	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—BCHE—malignant glioma	2.53e-05	0.000197	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	2.53e-05	0.000197	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	2.51e-05	0.000195	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STAT3—malignant glioma	2.51e-05	0.000195	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.5e-05	0.000194	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGF2—malignant glioma	2.5e-05	0.000194	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	2.43e-05	0.000189	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CASP3—malignant glioma	2.41e-05	0.000187	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL2—malignant glioma	2.4e-05	0.000187	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—malignant glioma	2.39e-05	0.000186	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STAT3—malignant glioma	2.36e-05	0.000184	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	2.34e-05	0.000182	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MDM2—malignant glioma	2.34e-05	0.000182	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MYC—malignant glioma	2.33e-05	0.000181	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RAF1—malignant glioma	2.33e-05	0.000181	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.3e-05	0.000179	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGFR—malignant glioma	2.28e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—malignant glioma	2.27e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.27e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.26e-05	0.000176	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.21e-05	0.000171	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MYC—malignant glioma	2.2e-05	0.000171	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.18e-05	0.00017	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KRAS—malignant glioma	2.15e-05	0.000167	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGFR—malignant glioma	2.15e-05	0.000167	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.11e-05	0.000164	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.09e-05	0.000162	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.09e-05	0.000162	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.04e-05	0.000159	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KRAS—malignant glioma	2.03e-05	0.000158	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.02e-05	0.000157	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.01e-05	0.000157	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	1.98e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—malignant glioma	1.97e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTEN—malignant glioma	1.96e-05	0.000153	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CAT—malignant glioma	1.96e-05	0.000152	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	1.92e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—malignant glioma	1.91e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MYC—malignant glioma	1.88e-05	0.000146	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	1.86e-05	0.000145	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.85e-05	0.000144	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGFR—malignant glioma	1.84e-05	0.000143	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—malignant glioma	1.8e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.77e-05	0.000138	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.76e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KRAS—malignant glioma	1.74e-05	0.000135	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MYC—malignant glioma	1.63e-05	0.000127	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKT1—malignant glioma	1.62e-05	0.000126	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.6e-05	0.000124	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.59e-05	0.000124	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—malignant glioma	1.54e-05	0.00012	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT1—malignant glioma	1.52e-05	0.000118	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CAV1—malignant glioma	1.51e-05	0.000117	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.51e-05	0.000117	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.39e-05	0.000108	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.37e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.34e-05	0.000104	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARG—malignant glioma	1.33e-05	0.000103	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.3e-05	0.000101	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.21e-05	9.39e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.13e-05	8.79e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.05e-05	8.19e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.04e-05	8.11e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTEN—malignant glioma	9.1e-06	7.07e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.42e-06	4.99e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKT1—malignant glioma	5.24e-06	4.08e-05	CbGpPWpGaD
